Literature DB >> 15651762

The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.

Marcelo H Losso1, Leonardo D Lourtau, Javier J Toibaro, César Saenz, Claudio González.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15651762

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


× No keyword cloud information.
  3 in total

1.  Pharmacokinetics of lopinavir in HIV-infected adults receiving rifampin with adjusted doses of lopinavir-ritonavir tablets.

Authors:  Eric H Decloedt; Helen McIlleron; Peter Smith; Concepta Merry; Catherine Orrell; Gary Maartens
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

2.  Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine.

Authors:  Kristina M Brooks; Jomy M George; Alice K Pau; Adam Rupert; Carolina Mehaffy; Prithwiraj De; Karen M Dobos; Anela Kellogg; Mary McLaughlin; Maryellen McManus; Raul M Alfaro; Colleen Hadigan; Joseph A Kovacs; Parag Kumar
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

3.  Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers.

Authors:  Christophe Schmitt; Myriam Riek; Katie Winters; Malte Schutz; Susan Grange
Journal:  Arch Drug Inf       Date:  2009-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.